We examined the humoral immune response to rotavirus infection in specific pathogen-free rabbits inoculated and challenged orally with rabbit Ala rotavirus (7.5 x i05 to 1 x 1 PFU). The humoral immune response in both serologic and mucosal samples was monitored by using total antibody enzyme-linked immunosorbent assays (ELISAs), isotype-specific ELISAs, and plaque reduction neutralization assays. Following a primary infection, all rabbits shed virus and serologic and mucosal antibody responses were initially detected by 1 week postinoculation. Intestinal immunoglobulin M was detected by 3 days postinoculation, and secretory immunoglobulin A was detected by 6 days postinoculation. Following challenge, rabbits were protected (no detectable virus shedding) from infection. An anamnestic immune response was observed only with mucosal neutralizing antibodies, and all serologic and mucosal immune responses persisted at high levels until at least 175 days postchallenge (204 days postinoculation). Detection of neutralization responses was influenced by the virus strain used in the neutralization assay; all inoculated rabbits developed detectable serum and intestinal neutralizing antibodies against the infecting (Ala) virus strain. Neutralization activity in both serum and mucosal samples was generally, but not exclusively, homotypic (VP7 serotype 3) after both primary and challenge inoculations with Ala virus. Heterotypic serum neutralization activity was observed with serotype 8 (9 of 12 rabbits) and 9 (12 of 12 rabbits) viruses and may be based on reactivity with the outer capsid protein VP4 or on a shared epitope in the C region of VP7. Comparisons of heterologous (serotype 3) and heterotypic neutralizing responses in mucosal and serologic samples revealed that 43% (21 of 49) of the responses were discordant. In 19 of 49 (39%) of these cases, a heterotypic serologic response was seen in the absence of a heterotypic mucosal response, but in 2 of 49 (4%) instances, a heterotypic mucosal response was seen in the absence of a concomitant serologic response. These results provide insight into factors which may affect detection of heterotypic responses.
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Rotaviruses are the maqor viral agents causing severe acute gastroenteritis in young children and animals. In developing countries rotavirus infections cause illness and death in children, while in developed countries rotavirusinduced diarrheal disease in children is associated with significant morbidity but less mortality (18, 32) . The significant impact of these infections has directed research efforts to the development of an effective vaccine. Currently, live attenuated and reassortant vaccines are being evaluated and subunit vaccines are being developed (8, 10, 11, 21, 34, 35, 51) .
The development of an effective vaccine would be facilitated by a clear understanding of the pathogenesis of virus infections and the mechanisms involved in eliciting a protective immune response. Many aspects of the immune response to rotavirus infection remain unclear. For example, what constitutes a protective immune response, the duration of the immune response, the proteins responsible for induction of a protective response, and the role of cell-mediated versus humoral immunity in protection remain to be elucidated. Early studies in animals determined that serum neutralizing antibodies alone were not sufficient for protection, and antibodies in the intestine were thought to be required (38, 47, 53 immune response to rotavirus infections in humans have primarily focused on the serologic responses in children following natural infection or vaccination. Elevated levels of anti-rotavirus serum IgG, IgM, and IgA and intestinal sIgA have been observed following infection or challenge in both humans and animals; the presence of intestinal antibodies is thought to be of primary importance in protection (1, 9, 14, 24, 27-29, 35, 43, 48, 52, 55) . These studies clearly indicate that the serum and intestinal immune responses are good indicators of a previous infection, but they provide little information on the protective immune response to rotavirus infection. Determining the critical response and best methods to monitor vaccine takes also requires understanding the kinetics and duration of the immune response(s) to rotavirus infection. Additionally, knowing how unprimed and primed individuals respond to infection and challenge will provide insights into the protective immune response.
The advantage of studying the immune response to infection in an animal model is that the viral exposure history is known and can be controlled. Only two animal models of rotavirus infection (rabbits and gnotobiotic piglets) closely mimic rotavirus infection in children and allow the study of active immune responses and protection. We have previously developed an animal model in specific pathogen-free rabbits to allow the systematic study of the active immune response to rotavirus infection and to evaluate subunit vaccines (12) . We now report the kinetics and serotype specificity of the humoral immune response in rabbits fol-lowing primary infection and subsequent challenge with a homologous rabbit rotavirus (Ala strain).
MATERIALS AND METHODS Virus. The Ala rabbit virus strain used for rabbit inoculations and SAl1, Cli, R2, W161, 69M, Ito, K8, DS-1, and St.
Thomas and the antiserum used for plaque reduction neutralization (PRN) were described previously (12, 16, 49) . All viruses used for PRN and enzyme-linked immunosorbent assays (ELISAs) were plaque purified three times.
Rabbits and animal inoculations. The rabbits used in this study were reared in individual isolator units as previously reported (12) . Rabbits of two age groups were studied. The inoculations and clinical and virologic parameters of the infection of young rabbits (39 to 55 days old) were described previously (12) . Briefly, seven young rabbits were inoculated and challenged (35 days postinoculation [DPI]) with 105 PFU of Ala rotavirus. Inoculation of five older rabbits (109 to 142 days old) was performed identically except the older rabbits were challenged at 29 DPI and inoculated with 107 PFU of Ala virus. The higher concentration of virus inoculum was used to ensure that 100% of the older rabbits would be infected and to determine whether a higher dose of virus would induce a higher incidence of diarrhea. As described previously for young rabbits inoculated with Ala, mild and moderate clinical signs were noted in 12 of 30 rabbits and 4 of 30 rabbits (12), respectively, and fluid accumulation and pathologic lesions in the intestine consistent with changes reported in other species (naturally or experimentally infected) were observed (19) . All older rabbits were infected (on the basis of virus shedding) after primary inoculation, but no difference in incidence of diarrhea (compared with 39-to 55-day-old rabbits) was observed. Older rabbits were maintained in open cages in a containment room for the primary infections and in individual units of a negativepressure isolation unit for the challenge inoculations.
Intestinal lavage procedure. Intestinal lavage samples were obtained, using a modification of the procedure of Burr et al. (5) . Rabbits were anesthetized with a mixture (0.7 ml/kg of body weight) containing 1 ml of acepromazine (10 mg/ml), 3 ml of ketamine (100 mg/ml), and 3 ml of xylazine (20 mg/ml). An 8 French infant feeding tube was passed orally into the stomach, and four doses of 10 to 15 ml of a lavage solution (0.025 M NaCl, 0.04 M Na2SO4, 0.01 M KCI, 0.02 M NaHCO3, 0.0485 M polyethylene glycol [molecular weight, 3,350]) were administered at 10-min intervals. One to 1.5 h after the last dose of lavage solution was administered, pilocarpine (4 mg/kg) (Sigma Chemicals) was given by intraperitoneal injection. Petri dishes were then placed under the floor racks of the cage to collect saliva and intestinal lavage fluids. Intestinal lavage samples were immediately filtered through cheesecloth, the filtrate was frozen at -20°C, and samples were processed within 3 days of collection to inhibit proteolytic degradation of immunoglobulins. For processing, protease inhibitors (phenylmethylsulfonyl fluoride [final concentration, 0.001 M] and soybean trypsin inhibitor [80 mg/ml in 50 mM EDTA]) were added to the samples prior to thawing at 37°C. The samples were then heat inactivated (15 min at 56°C) and cooled in ice; after being diluted (1:5) with sterile phosphate-buffered saline (PBS) containing Tween 20 (0.1%), soybean trypsin inhibitor (0.1 mg/ml), and thimerosal (0.1 mg/ml), the samples were vortexed and clarified by centrifugation at 600 x g for 10 min. ELISA to measure total antibody to rotavirus. After microtiter plates were coated with a hyperimmune guinea pig serum to Ala virus, blocked, and washed, Ala virus (diluted to the concentration necessary to obtain a standard titer of the positive control rabbit serum) or 1/10 BLOTTO was added and incubated for 1 h. After one wash, the test sample was added and serially diluted twofold in the plate and incubated for 1 h. After another wash, horseradish peroxidase-conjugated goat anti-rabbit IgA, IgM, and IgG (Cappel, Organon Teknika, West Chester, Pa.) was added and the VOL. 65, 1991 on November 6, 2017 by guest http://jvi.asm.org/ Downloaded from plates were incubated for 1 h. After a final wash, the substrate was added and the A414 was read.
ELISA to measure anti-rotavirus mucosal IgM. Microtiter plates were coated with goat anti-rabbit IgM (Cappel), blocked, and washed, and the processed lavage or intestinal content sample was serially diluted twofold in duplicate wells and incubated for 2 h. The coating antibody was preabsorbed with SAl1-infected MA-104 cells and mouse liver powder (Cappel) to remove antibodies to rotavirus. The plates containing the intestinal sample were washed, Ala virus (diluted to obtain a standard endpoint titer of the positive control lavage sample) or 1/10 BLOTTO was added to each of duplicate wells, and the plates were incubated for 1 h. Following the wash, guinea pig hyperimmune serum to Ala virus was added to the wells and incubated for 1 h. The plates were then washed, and horseradish peroxidase-conjugated goat anti-guinea pig IgG (Cappel) was added and incubated for 1 h. After another wash, substrate was added and the A414 was read.
ELISA to measure sIgA concentration in intestinal samples. After microtiter plates were coated with goat anti-rabbit sIgA (Cappel), blocked, and washed, duplicate serial twofold dilutions of intestinal or lavage samples were made in the plate and incubated for 1 h. A sIgA standard (kindly provided by David Keren, University of Michigan Medical Center) was also included on each plate. Serial two-or fivefold dilutions of the standard were made in the plate starting with 20 Fg/ml. After a wash, horseradish peroxidase-conjugated goat anti-rabbit sIgA (kindly provided by Richard Wistar, Jr., Naval Research Institute) was added and incubated for 1 h. After another wash, ABTS was added, and the A414 was read.
A standard curve was plotted for the dilutions of sIgA standard on each plate. Linear regression analyses were then used to determine the concentration of sIgA in each sample.
Only those values of the standard that were limiting concentrations (in a linear range) were included in the linear regression analysis (r = 0.96 to 0.99; r2 = 0.92 to 0.98). The sIgA concentration was calculated from a dilution of the sample with an A414 value between 0.2 and 0.3 (a point at which the sIgA in the sample was the limiting reagent). The ranges of sIgA concentrations in small intestinal content and lavage samples were 25 to 271 and 174 to 5,051 ,ug/ml, respectively. The concentration of sIgA in sequential lavage samples from individual rabbits varied from sample to sample. For five rabbits from which sequential lavage samples were collected, the differences in sIgA concentration between the lowest and highest sIgA concentration for two to eight samples from each rabbit were 1.1-, 3.3-, 3.9-, 14.4-, and 17.8-fold. These differences in concentrations required the normalization (based on sIgA concentration) of the mucosal sIgA and neutralization titers.
ELISA to measure anti-rotavirus mucosal sIgA. The coating, blocking, washing, and addition of antigen (Ala virus) steps were performed in an identical manner as for the total antibody ELISA (see above). Lavage or intestinal content samples were then added, serially diluted twofold in the plate, and incubated for 2 h. After a wash, the plates were incubated with horseradish peroxidase-conjugated affinitypurified goat anti-rabbit sIgA for 1 h. After a final wash, ABTS was added and the A414 was determined. To compare titers, all samples were normalized to 1 mg of sIgA per ml (to control for differences in titer due to variation of sIgA concentration in lavages). 
RESULTS
Kinetics of the serologic immune response measured by ELISA. Total (IgG, IgM, and IgA) serum antibody responses to homologous virus following Ala inoculation and challenge were measured by ELISA in rabbits of two age groups. In seven young rabbits, an immune response was detectable as early as 5 DPI and all rabbits seroconverted by 9 DPI. Peak antibody titers developed by 14 to 21 DPI (Fig. 1) . Similar kinetics were observed in the five older rabbits; all rabbits seroconverted by 7 DPI and peak titers developed by 16 to 29 DPI (Fig. 1 ). An anamnestic response (greater than a fourfold increase in titer) was not observed in either group following challenge.
Kinetics of the serologic neutralizing antibody response to homologous virus measured by PRN. Rabbits of both ages inoculated with Ala virus and challenged at 29 or 35 DPI were completely protected from challenge, as determined by virus excretion (12) . Sequential serum samples from these rabbits were analyzed for neutralizing antibodies to Ala virus. Primary neutralizing antibodies to homologous Ala virus were first detected at 7 to 9 DPI (Fig. 2) . All rabbits had neutralizing antibodies by 16 to 21 DPI. Serum neutralizing antibodies were detected by 7 DPI in older rabbits but their initial appearance was delayed (9 to 21 DPI) in younger rabbits. However, this delay apparently reflects a technical artifact produced by using a higher initial serum dilution (1:200) in the assays, necessary because of the small volumes of serum (0.5 to 1.0 ml) collected from these young rabbits. When serum samples from five of the seven young rabbits were retested for neutralizing antibodies at a 1:50 dilution, four of five rabbits seroconverted by 9 DPI. Neutralizing titers on the day of challenge (29 or 35 DPI) ranged from 1:530 to 1:2,150 in the younger rabbits and 1:780 to 1:2,300 (P > 0.05 for differences in titer) in the older rabbits. All the rabbits were completely protected from challenge (data not shown), and an anamnestic neutralization response was not observed following challenge. In the older rabbits, neutralizing antibodies were maintained following challenge in the absence of antigen reexposure (animals were housed in positive-pressure isolators) to at least 175 days postchallenge (DPC) (which was 204 DPI) and antibody titers remained stable during this period.
Homotypic and heterotypic serologic neutralizing antibody. (Table 3) . Specific sIgA antibodies were detected in all the intestinal samples collected postchallenge ( Table 3) . The kinetics and persistence of the intestinal sIgA response were also examined in sequential lavage samples collected from individual older rabbits following primary and challenge inoculation (Table 6 ). No anti-rotavirus sIgA responses were detected in lavage samples collected prior to inoculation from 2 rabbits or from uninfected littermates (11 animals). As in the experiments in the younger rabbits, a sIgA response was present by 7 DPI ( (7 DPI) . The IgM response was short-lived; it could not be detected after 7 DPI in the older rabbits. Intestinal neutralizing antibodies were induced early, were detectable at 5 DPI, and were present in all rabbits by 7 DPI. It is interesting that the appearance of an intestinal antibody response correlated with the time of virus clearance and was possibly involved in virus clearance and clinical recovery from primary rotavirus infection. Additional specific responses may also be needed for complete recovery. Others have suggested that cell-mediated immune responses may be important in recovery from primary infection (39) (40) (41) and that persistent excretion of virus from animals or children with severe combined immunodeficiency indicates other factors are necessary to effectively mediate complete virus clearance (15, 44, 46) .
The duration of the primary and secondary immune responses to rotavirus infection is difficult to assess in populations in which natural reexposure to rotavirus cannot be prevented. Long-term isolation of rabbits allowed us to design experiments to ensure that no antigenic stimulation (besides the primary and challenge inoculation) occurred. Use of homologous virus in all ELISAs and PRN assays resulted in increased test sensitivity. Under these conditions, we found that all inoculated rabbits exhibited both serologic and mucosal antibody responses and these responses were maintained for the duration of each experiment. The serologic response was maintained at essentially The immune response in unprimed rabbits was readily detected by measuring either serologic or intestinal antibody conversion. In contrast, after rabbits were challenged with homologous virus, no additional serologic antigenic stimulation was seen. Because the rabbits were completely protected from challenge (no virus excretion), the concentration of anti-rotavirus neutralizing antibody or sIgA in the intestine after the primary infection may have prevented reinfection and restimulation of the serologic immune system (33, 45) . A similar lack of a serologic response after rotavirus challenge has been observed in rabbits and calves (4, 25 In several studies in apparently seronegative children, heterotypic neutralizing antibody responses have been observed following natural infections (7, 9) . Results from these early studies must be interpreted with caution, since a previous exposure to rotavirus cannot be ruled out. More recent studies have attempted to monitor unprimed children. Following rotavirus infections in children in China, the neutralizing antibody response (measured within 2 weeks of infection) was found to be serotype specific in 29 of 30 children, although 9 of these children had preexisting (presumably maternal) antibodies in their acute-phase sera (56) . Unprimed children vaccinated with MMU18006 or monovalent reassortants of rhesus monkey rotavirus produced only homotypic antibodies, while the same vaccine in older children and adults induced heterotypic antibodies (23, 35 (50, 54) . Again, our results suggest that mucosal responses may need to be measured when evaluating immune responses to prospective vaccines.
We also examined the immune responses in six additional young rabbits with passively derived serum antibodies to determine the effect of preexisting maternally derived antibodies on the immune response to infection (data not shown). Preexisting total serum antibodies, but not neutralizing antibodies, were present at 0 DPI (titers of 1:200). The immune response in rabbits with preexisting maternal antibodies did not differ from that seen in antibody-negative rabbits. This lack of interference may have been because preexisting antibody titers were low and no neutralizing antibodies were present. Because rabbits mimic humans in many immunologic parameters (such as transplacental transfer of antibodies), this model will be useful to more fully examine how preexisting antibodies might affect primary viral infections (or vaccine takes) and the primary antibody response to infection. Methods to overcome interference can also be examined. Poor responses and low percentage of vaccine takes in children have been attributed to interference by maternal antibodies and they are a continuing problem in the administration of live vaccines to young children (6, 17) .
We and others (25) initially developed this animal model in rabbits with the idea that information obtained with it will be helpful for understanding active immune responses in children. Several studies (published while our analyses were being completed) confirm this idea by showing similar kinetics of the isotype intestinal immune response to a rotavirus infection in children to our results in rabbits (1, 2, 13, 24, 27, 48). The similarity of our results to those found recently in children further validate the utility of the rabbit model for immunologic studies of rotavirus infections. A major advantage of this model is the fact that responses can be analyzed without the confounding variables of possible undetected exposure and priming to unknown viruses which occur very early in life in children. Future uses of the model include studies to examine the immune response to individual rotavirus proteins, the effect of preexisting antibody on immune responses, the effect of virus dose on the immune response, the duration of the immune response to a primary infection, and the efficacy of subunit vaccines to induce protection from challenge.
